Bruno Baillavoine

Proven Business builder, with a record of strong profitability from small Companies to Multinationals. A UK Director of Pericles Group: Leading Consulting firm, an expert in Banking and Finance with over 350 institutional clients./ Director of Cel-Sci Corporation, an NYSE Company focused on activating the immune system to fight cancer and infectious diseases. Director of an International Investor Relations Firm in Life Science and Technology./ Seating on the other UK and North American Boards.

Mr Baillavoine was Director for a US$325m Initial-UK (BET Plc). Promoted MD for the manufacturing businesses. BET’s US$3.75 billion turnarounds were the most successful turnaround of an FTSE 100.

Previously Director for the Special Operations Division of Grand Metropolitan Plc (now Diageo Plc $70 Billion Market Cap).Early career includes Director of  Prontaprint Plc; the Co grew to 100’s of locations and a successful UK float over 4 years, French and U.S. Education.

‍